Covidien Announces Latest Advance In “Unite To Treat Sleep Apnea” Initiative

Covidien (NYSE: COV, BSX: COV), a leading global healthcare products company, announced the latest advance in its “Unite to Treat Sleep Apnea” initiative, an integrated program connecting physicians, sleep labs, treatment providers and patients to improve the diagnosis and treatment of those afflicted with obstructive sleep apnea.

More: continued here

Filed under: Sleep / Sleep Disorders on June 30th, 2008